Richard L. Wang Named Chief Executive Officer of Fosun Kite Biotechnology Co., Ltd., a Joint Venture to Lead Development of Axicabtagene Ciloleucel and Other Engineered T-Cell Therapies for Treatment Mar 5, 2017 04:00PM
Kite Pharma (KITE) & Fosun Pharma Establish Chinese Joint Venture, Will Develop And Commercialize Autologous T-Cell Therapies For Cancer Treatment Jan 10, 2017 03:45AM
Kite Pharma and Fosun Pharma Establish Joint Venture in China to Develop and Commercialize Autologous T-Cell Therapies to Treat Cancer Jan 10, 2017 03:30AM